Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii

BACKGROUND: Tigecycline, with broad in vitro antibacterial activity, has been widely used off-label for nosocomial pneumonia caused by multi-drug resistant Acinetobacter baumannii (MDRAB). However, many concerns have been raised about the efficacy of tigecycline treatment as the inconsistent results...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Pharmacol Toxicol
Prif Awduron: Zhou, Yangang, Chen, Xumin, Xu, Ping, Zhu, Yan, Wang, Kuangguo, Xiang, Daxiong, Wang, Feng, Banh, Hoan Linh
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2019
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482491/
https://ncbi.nlm.nih.gov/pubmed/31023357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-019-0300-3
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg